Company · CIK 1645569
DICE Therapeutics, Inc.
| CIK | 1645569 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-11-12 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-267702 | 2022-10-03 | 2023-08-10 | 5 | |
| 333-270581 | 2023-03-15 | 2023-03-15 | 1 | |
| 333-259061 | 2021-08-25 | 2021-09-16 | 5 |
Filings
12| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-08-10 | EFFECTDeclared effective | 333-267702 | 9999999995-23-002334 |
| 2023-03-15 | S-3ASRShelf registered | 333-270581 | 0001193125-23-071466 |
| 2022-10-13 | 424B5Shelf takedown | 333-267702 | 0001193125-22-262154 |
| 2022-10-11 | 424B5Shelf takedown | 333-267702 | 0001193125-22-260619 |
| 2022-10-07 | EFFECTDeclared effective | 333-267702 | 9999999995-22-002992 |
| 2022-10-03 | S-3Shelf registered | 333-267702 | 0001193125-22-256208 |
| 2021-09-16 | 424B4Final prospectus | 333-259061 | 0001193125-21-274351 |
| 2021-09-14 | EFFECTDeclared effective | 333-259061 | 9999999995-21-003516 |
| 2021-09-09 | S-1/AAmendment | 333-259061 | 0001193125-21-268271 |
| 2021-08-27 | S-1/AAmendment | 333-259061 | 0001193125-21-259250 |
| 2021-08-25 | S-1Registration filed | 333-259061 | 0001193125-21-256368 |
| 2021-07-02 | DRSDraft made public | 377-05139 | 0000950123-21-008434 |